Categories
· Health/Science
Organizations
· Iom
|
Jump to full article: The National Academies, 2001-02-22
Author: Stuart Bondurant
Intro: The conclusions of our report can be summarized in four points.
Harm reduction through risk-reducing tobacco or other products is feasible, although to date none have been proved to be effective.
Without intensive study, it is not possible to say whether these products reduce risk to the individual or actually increase the likelihood of harm.
Unless the risks of increased harm are known and controlled, neither individuals nor responsible officials can make informed decisions about these products.
Risks of increased harm cannot be known and controlled without regulation. . .
In 1999, the Food and Drug Administration asked the IOM to assess the scientific basis for possible harm reduction from the use of tobacco. The IOM assembled a committee, which I chaired, composed of experts in medicine, pharmacology, epidemiology, public policy, and toxicology. We worked for more than a year gathering data and reviewing the scientific literature.
Jump to full article » |